Domain walls in three dimensional gauged supergravity

We explicitly construct two Chern-Simons gauged supergravities in three dimensions with N=4 and N=8 supersymmetries and non-semisimple gauge groups. The N=4 theory has scalar manifold $SO(4,3)/SO(4)\times SO(3)$ with the gauge group $SO(3)\ltimes (\mathbf{T}^3,\hat{\mathbf{T}}^3)$. The theory describes (1,0) six dimensional supergravity reduced on an SU(2) group manifold. The equivalent Yang-Mills type gauged supergravity has SO(3) gauge group coupled to three massive vector fields. The N=8 theory is described by $SO(8,8)/SO(8)\times SO(8)$ scalar manifold, and the gauge group is given by $SO(8)\ltimes \mathbf{T}^{28}$. The theory is a truncation of the $SO(8)\ltimes \mathbf{T}^{28}$ gauged N=16 theory with scalar manifold $E_{8(8)}/SO(16)$ and can be obtained by an S^7 compactification of type I theory in ten dimensions. Domain wall solutions of both gauged supergravities are analytically found and can be uplifted to higher dimensions. These provide domain wall vacua in the three dimensional gauged supergravity framework which might be useful for the study of Domain Wall$_3$/QFT$_2$ correspondence.Comment: 19 pages, no figures, typoes and a mistake in a sign corrected, clarifications on the notations adde

Effectiveness and cost-effectiveness of an exposure-based return-to-work programme for patients on sick leave due to common mental disorders: design of a cluster-randomized controlled trial

<p>Abstract</p> <p>Background</p> <p>To reduce the duration of sick leave and loss of productivity due to common mental disorders (CMDs), we developed a return-to-work programme to be provided by occupational physicians (OPs) based on the principles of exposure in vivo (RTW-E programme). This study evaluates this programme's effectiveness and cost-effectiveness by comparing it with care as usual (CAU). The three research questions we have are: 1) Is an RTW-E programme more effective in reducing the sick leave of employees with common mental disorders, compared with care as usual? 2) Is an RTW-E programme more effective in reducing sick leave for employees with anxiety disorders compared with employees with other common mental disorders? 3) From a societal perspective, is an RTW-E programme cost-effective compared with care as usual?</p> <p>Methods/design</p> <p>This study was designed as a pragmatic cluster-randomized controlled trial with a one-year follow-up and randomization on the level of OPs. We aimed for 60 OPs in order to include 200 patients. Patients in the intervention group received the RTW-E programme. Patients in the control group received care as usual. Eligible patients had been on sick leave due to common mental disorders for at least two weeks and no longer than eight weeks. As primary outcome measures, we calculated the time until full return to work and the duration of sick leave. Secondary outcome measures were time until partial return to work, prevalence rate of sick leave at 3, 6, 9, and 12 months' follow-up, and scores of symptoms of distress, anxiety, depression, somatization, and fatigue; work capacity; perceived working conditions; self-efficacy for return to work; coping behaviour; avoidance behaviour; patient satisfaction; and work adaptations. As process measures, we used indices of compliance with the intervention in the intervention group and employee-supervisor communication in both groups. Economic costs were calculated from a societal perspective. The total costs consisted of the costs of consuming health care, costs of production loss due to sick leave and reduced productivity, and out-of-pocket costs of patients for travelling to their OP.</p> <p>Discussion</p> <p>The results will be published in 2009. The strengths and weaknesses of the study protocol are discussed.</p> <p>Trial registration</p> <p>ISRCTN72643128</p

Corrigendum: Whole genome analysis of a schistosomiasis-transmitting freshwater snail

This corrects the article DOI: 10.1038/ncomms15451

Incorporação de novos medicamentos pela Comissão Nacional de Incorporação de Tecnologias do SUS, 2012 a junho de 2016 / Incorporation of new medicines by the National Commission for Incorporation of Technologies, 2012 to June 2016

The National Commission for incorporation of Health Technologies (CONITEC), established in 2011, advises the Ministry of Health in decisions related to the incorporation, exclusion or change of medicines, products and procedures in the Unified Health System (SUS).The study investigated the decision-making process, profile of demands and incorporation of new medicines in the SUS from January/2012 to June/2016, based on data available on the CONITEC website. All submissions were evaluated and characterized by technology and applicant type. The incorporations were analyzed according to the Anatomical-Therapeutic-Chemical classification, International Classification of Disease of the clinical indication and active record in the National Health Surveillance Agency. In the period, 485 submissions were received, 92.2% concerning requests for incorporation and 62.1% for medicines, of which 93 (30.1%) received a favorable recommendation for incorporation. Domestic demands were more successful than externally originated ones. Six unregistered drugs were incorporated. Infectious and parasitic diseases and musculoskeletal diseases constituted the main clinical indications. The recommendation of incorporation occurred mainly based on the additional clinical benefits and low budget impact

Sulfato de amônio e uréia em cobertura no milho em semeadura direta no Cerrado

A aplicação de nitrogênio no milho de forma antecipada, tanto na semeadura da planta de cobertura como em pré-semeadura pode otimizar os trabalhos dentro da propriedade. Objetivou-se avaliar a influência nas concentrações foliares e produtividade de grãos do milho do parcelamento do nitrogênio suplementar à semeadura em área de dois anos de soja, em solo de textura média e quantificar a recuperação do nitrogênio do sulfato de amônio e da úreia, utilizando a técnica da diluição isotópica (15N). Os tratamentos constaram da aplicação de 110 kg ha-1 de nitrogênio em épocas distintas: na semeadura do milheto -5 dias antes da semeadura do milho -em cobertura, quando as plantas tinham 5-7 folhas; -e em cobertura quando as plantas tinham 9-10 folhas. Há diferença de produtividade de grãos e concentrações foliares de nitrogênio, fósforo, cálcio e enxofre quando se aplica nitrogênio suplementar à semeadura em diferentes épocas em relação a ausência de fertilização. O parcelamento de 110 kg ha-1 entre pré-semeadura e cobertura ou apenas na cobertura não altera a recuperação total do fertilizante. A recuperação do nitrogênio do sulfato de amônio aplicado em cobertura é maior quando comparada à uréia, sendo ainda que o parcelamento de sulfato de amônio em cobertura apresenta maior recuperação em relação ao fornecimento em uma única aplicação